Identifying multi-omics biomarkers for ovarian cancer survival estimation
Ovarian cancer is among the deadliest gynecologic malignancies, and its molecular heterogeneity limits accurate prognostic stratification. Although multi-omics approaches have improved predictive modeling, many prioritize predictive performance over biological interpretability, limiting their clinical translation. We developed an interpretable three-stage machine learning framework integrating…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.